Healthcare, Regulatory and Reimbursement Landscape - Philippines Market Expected to Grow at CAGR of 9.4% Between Years 2016-2020

The Report CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -


Albany, NY -- (SBWIRE) -- 12/08/2016 -- GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines. The report is an essential source of information and analysis regarding the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure in the country. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. This resource has been produced using data and information from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

View Report At

The population of the Philippines amounted to approximately 99.2 million in 2013, making it the 12th most populated country in the world. Population growth has primarily been due to a high birth rate and rising life expectancy. An increased elderly population is however a matter of concern for policy planners. The value of the pharmaceutical market in the country amounted to $4.3 billion in 2013, and it is expected to increase at a CAGR of 9.4% to reach approximately $8 billion in 2020.

The positive trend in the healthcare market of the Philippines can be attributed primarily to the following factors -
- Generic substitution in both the public and private sectors, which has been a driver for the manufacture of generic drugs
- Increased expenditure on medicines by Local Government Units (LGUs)
- Government initiatives for the prevention and management of chronic diseases
- An improved and updated regulatory environment

Download Sample copy of this Report at :


This report provides information on the healthcare, regulatory, and reimbursement landscape in the Philippines, including the following -

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses for major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck)
- An insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure
- An overview of the opportunities for and challenges facing growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

- Develop business strategies based on a sound understanding of the trends shaping and driving the healthcare market in the Philippines
- Generate revenue based upon knowledge of key trends, reimbursement and regulatory policies, pharmaceutical market segments, and the companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize sales and marketing efforts by identifying the market categories and segments that present the greatest opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize upon the opportunities and challenges in the Philippines healthcare market

Table of Contents

1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 16
2.1 GlobalData Report Guidance 16
3 Overview of Pharmaceutical and Medical Device Market 17
3.1 Pharmaceutical Market 17
3.1.1 Market Overview 17
3.1.2 Pharmaceutical Exports and Imports 21
3.1.3 Supply Channels 22
3.1.4 Market Segments 24
3.1.5 Overview of Major Disease Areas 26
3.1.6 Major Players 28
3.2 Medical Device Market 70
3.2.1 Market Overview 70
3.3 Market Drivers and Barriers 70
3.3.1 Drivers 70
3.3.2 Barriers 71
4 Market Access 73
4.1 Reimbursement and Payer Landscape 73
4.1.1 Overview of Healthcare system 73
4.1.2 Reimbursement Process 74
4.1.3 Overview of Insurance Providers 78
4.1.4 Patient Share in Healthcare Spending 82
4.1.5 Price Trends in the Healthcare Sector 83
4.1.6 Pricing Policies 84
4.2 Regulatory Landscape 86
4.2.1 Overview of Regulatory Agencies 86
4.2.2 Market Authorization Procedure for Pharmaceutical Products 87
4.2.3 New Medical Device Approval Process 94
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 94
4.2.5 Exports and Imports 95
4.2.6 Intellectual Property Rights 99
4.2.7 Clinical Trial Regulations 102
4.2.8 Pharmaceutical Advertising Regulations 105
4.2.9 Pharmacy Regulations 106
4.2.10 Labeling and Packaging Regulations 107
5 Country Analysis 109
5.1 Political Environment 109
5.1.1 Political Structure 109
5.1.2 Analysis of Current Political Environment 109
5.1.3 Healthcare Policy Initiatives 110
5.2 Economic Landscape 112
5.3 Economic Indicators 115
5.3.1 Gross Domestic Product 115
5.3.2 Gross National Income 120

About is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074